By Daily Press staff
Analytical Sciences Inc., a professional services company focused on enhancing human health, announced Wednesday that it has acquired Protocare Sciences, an evidenced-based, health-care consulting and analytic services business based in Santa Monica, Calif.
Protocare Sciences, which has experienced more than a 65 percent compounded growth in the consulting business since 1998, helps pharmaceutical, biotechnolo-gy and medical device companies across the world accelerate medical therapies to market. It previously operated as one of three divisions of Protocare Inc., a large provider of drug development services to clients in the pharmaceutical, biotechnol-ogy and nutrition fields. Prior to becoming a Protocare company in 1998, Protocare Sciences was part of the former Value Health Inc.
Under the acquisition, Protocare Sciences will operate as a separate business. ASI will provide significant operational support, expected to help the consulting company grow its revenues more than 300 percent in the next three years.
As part of the acquisition, Donato Tramuto, one of the founders of Protocare Inc., will continue to serve as Protocare Sciences’ president and CEO. In addition, ASI has retained all of the strategic consultants, analysts and support personnel from Protocare Sciences, bringing ASI’s total employee base to more than 600. Protocare Sciences employees work from company offices in Santa Monica, Herndon, Va., and Boston, and from their home offices across the United States.
“Protocare Sciences is now better positioned to expand its business and services to a higher level,” said Tramuto. “It is indeed exciting to be part of an organization that has demonstrated unprecedented growth and commitment to expanding through the basic principles of organic positioning, internal leveraging and acquisition strategies. We are very fortunate to start off this year with a platform that assures our continued growth.”
The company will continue to deliver high-level, evidence-based consulting services to pharmaceutical and biotech-nology companies, managed-care organizations, pharmacy benefit managers, foundations and health-policy groups.
“Our business will continue to operate with the same quality and value that our clients have come to expect without interruption," said Tramuto. “The biggest difference is that through the investments of ASI, we will be able to both optimize and expand our suite of services to meet the needs of our clients and the marketplace.”
Originally published in the Santa Monica Daily Press print edition on January 9, 2003. Read the original PDF.